1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vitamin E and Pioglitazone
1.2.3 Ocaliva
1.2.4 Elafibranor
1.2.5 Selonsertib and Cenicriviroc
1.3 Market by Application
1.3.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NASH Therapeutic Drugs Market Perspective (2017-2028)
2.2 NASH Therapeutic Drugs Growth Trends by Region
2.2.1 NASH Therapeutic Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NASH Therapeutic Drugs Historic Market Size by Region (2017-2022)
2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Region (2023-2028)
2.3 NASH Therapeutic Drugs Market Dynamics
2.3.1 NASH Therapeutic Drugs Industry Trends
2.3.2 NASH Therapeutic Drugs Market Drivers
2.3.3 NASH Therapeutic Drugs Market Challenges
2.3.4 NASH Therapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NASH Therapeutic Drugs Players by Revenue
3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2017-2022)
3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2017-2022)
3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue
3.4 Global NASH Therapeutic Drugs Market Concentration Ratio
3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2021
3.5 NASH Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players NASH Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into NASH Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NASH Therapeutic Drugs Breakdown Data by Type
4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2017-2022)
4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2023-2028)
5 NASH Therapeutic Drugs Breakdown Data by Application
5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2017-2022)
5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NASH Therapeutic Drugs Market Size (2017-2028)
6.2 North America NASH Therapeutic Drugs Market Size by Type
6.2.1 North America NASH Therapeutic Drugs Market Size by Type (2017-2022)
6.2.2 North America NASH Therapeutic Drugs Market Size by Type (2023-2028)
6.2.3 North America NASH Therapeutic Drugs Market Share by Type (2017-2028)
6.3 North America NASH Therapeutic Drugs Market Size by Application
6.3.1 North America NASH Therapeutic Drugs Market Size by Application (2017-2022)
6.3.2 North America NASH Therapeutic Drugs Market Size by Application (2023-2028)
6.3.3 North America NASH Therapeutic Drugs Market Share by Application (2017-2028)
6.4 North America NASH Therapeutic Drugs Market Size by Country
6.4.1 North America NASH Therapeutic Drugs Market Size by Country (2017-2022)
6.4.2 North America NASH Therapeutic Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe NASH Therapeutic Drugs Market Size (2017-2028)
7.2 Europe NASH Therapeutic Drugs Market Size by Type
7.2.1 Europe NASH Therapeutic Drugs Market Size by Type (2017-2022)
7.2.2 Europe NASH Therapeutic Drugs Market Size by Type (2023-2028)
7.2.3 Europe NASH Therapeutic Drugs Market Share by Type (2017-2028)
7.3 Europe NASH Therapeutic Drugs Market Size by Application
7.3.1 Europe NASH Therapeutic Drugs Market Size by Application (2017-2022)
7.3.2 Europe NASH Therapeutic Drugs Market Size by Application (2023-2028)
7.3.3 Europe NASH Therapeutic Drugs Market Share by Application (2017-2028)
7.4 Europe NASH Therapeutic Drugs Market Size by Country
7.4.1 Europe NASH Therapeutic Drugs Market Size by Country (2017-2022)
7.4.2 Europe NASH Therapeutic Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NASH Therapeutic Drugs Market Size (2017-2028)
8.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type
8.2.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific NASH Therapeutic Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Application
8.3.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific NASH Therapeutic Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific NASH Therapeutic Drugs Market Size by Region
8.4.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NASH Therapeutic Drugs Market Size (2017-2028)
9.2 Latin America NASH Therapeutic Drugs Market Size by Type
9.2.1 Latin America NASH Therapeutic Drugs Market Size by Type (2017-2022)
9.2.2 Latin America NASH Therapeutic Drugs Market Size by Type (2023-2028)
9.2.3 Latin America NASH Therapeutic Drugs Market Share by Type (2017-2028)
9.3 Latin America NASH Therapeutic Drugs Market Size by Application
9.3.1 Latin America NASH Therapeutic Drugs Market Size by Application (2017-2022)
9.3.2 Latin America NASH Therapeutic Drugs Market Size by Application (2023-2028)
9.3.3 Latin America NASH Therapeutic Drugs Market Share by Application (2017-2028)
9.4 Latin America NASH Therapeutic Drugs Market Size by Country
9.4.1 Latin America NASH Therapeutic Drugs Market Size by Country (2017-2022)
9.4.2 Latin America NASH Therapeutic Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NASH Therapeutic Drugs Market Size (2017-2028)
10.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type
10.2.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa NASH Therapeutic Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Application
10.3.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa NASH Therapeutic Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa NASH Therapeutic Drugs Market Size by Country
10.4.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan Plc (Tobira)
11.1.1 Allergan Plc (Tobira) Company Details
11.1.2 Allergan Plc (Tobira) Business Overview
11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction
11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2017-2022)
11.1.5 Allergan Plc (Tobira) Recent Developments
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction
11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2017-2022)
11.2.5 Bristol Myers Squibb Recent Developments
11.3 Galmed Pharmaceuticals
11.3.1 Galmed Pharmaceuticals Company Details
11.3.2 Galmed Pharmaceuticals Business Overview
11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction
11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2017-2022)
11.3.5 Galmed Pharmaceuticals Recent Developments
11.4 Genfit SA
11.4.1 Genfit SA Company Details
11.4.2 Genfit SA Business Overview
11.4.3 Genfit SA NASH Therapeutic Drugs Introduction
11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2017-2022)
11.4.5 Genfit SA Recent Developments
11.5 Gilead Sciences, Inc.
11.5.1 Gilead Sciences, Inc. Company Details
11.5.2 Gilead Sciences, Inc. Business Overview
11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction
11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)
11.5.5 Gilead Sciences, Inc. Recent Developments
11.6 Intercept Pharmaceuticals, Inc.
11.6.1 Intercept Pharmaceuticals, Inc. Company Details
11.6.2 Intercept Pharmaceuticals, Inc. Business Overview
11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction
11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)
11.6.5 Intercept Pharmaceuticals, Inc. Recent Developments
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Details
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction
11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2017-2022)
11.7.5 Zydus Cadila Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Vitamin E and Pioglitazone
Table 3. Key Players of Ocaliva
Table 4. Key Players of Elafibranor
Table 5. Key Players of Selonsertib and Cenicriviroc
Table 6. Global NASH Therapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global NASH Therapeutic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global NASH Therapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global NASH Therapeutic Drugs Market Share by Region (2017-2022)
Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global NASH Therapeutic Drugs Market Share by Region (2023-2028)
Table 12. NASH Therapeutic Drugs Market Trends
Table 13. NASH Therapeutic Drugs Market Drivers
Table 14. NASH Therapeutic Drugs Market Challenges
Table 15. NASH Therapeutic Drugs Market Restraints
Table 16. Global NASH Therapeutic Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global NASH Therapeutic Drugs Revenue Share by Players (2017-2022)
Table 18. Global Top NASH Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2021)
Table 19. Ranking of Global Top NASH Therapeutic Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players NASH Therapeutic Drugs Product Solution and Service
Table 23. Date of Enter into NASH Therapeutic Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global NASH Therapeutic Drugs Revenue Share by Application (2017-2022)
Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global NASH Therapeutic Drugs Revenue Share by Application (2023-2028)
Table 33. North America NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific NASH Therapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific NASH Therapeutic Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 63. Allergan Plc (Tobira) Company Details
Table 64. Allergan Plc (Tobira) Business Overview
Table 65. Allergan Plc (Tobira) NASH Therapeutic Drugs Product
Table 66. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
Table 67. Allergan Plc (Tobira) Recent Developments
Table 68. Bristol Myers Squibb Company Details
Table 69. Bristol Myers Squibb Business Overview
Table 70. Bristol Myers Squibb NASH Therapeutic Drugs Product
Table 71. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
Table 72. Bristol Myers Squibb Recent Developments
Table 73. Galmed Pharmaceuticals Company Details
Table 74. Galmed Pharmaceuticals Business Overview
Table 75. Galmed Pharmaceuticals NASH Therapeutic Drugs Product
Table 76. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
Table 77. Galmed Pharmaceuticals Recent Developments
Table 78. Genfit SA Company Details
Table 79. Genfit SA Business Overview
Table 80. Genfit SA NASH Therapeutic Drugs Product
Table 81. Genfit SA Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
Table 82. Genfit SA Recent Developments
Table 83. Gilead Sciences, Inc. Company Details
Table 84. Gilead Sciences, Inc. Business Overview
Table 85. Gilead Sciences, Inc. NASH Therapeutic Drugs Product
Table 86. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
Table 87. Gilead Sciences, Inc. Recent Developments
Table 88. Intercept Pharmaceuticals, Inc. Company Details
Table 89. Intercept Pharmaceuticals, Inc. Business Overview
Table 90. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product
Table 91. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
Table 92. Intercept Pharmaceuticals, Inc. Recent Developments
Table 93. Zydus Cadila Company Details
Table 94. Zydus Cadila Business Overview
Table 95. Zydus Cadila NASH Therapeutic Drugs Product
Table 96. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
Table 97. Zydus Cadila Recent Developments
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NASH Therapeutic Drugs Market Share by Type: 2021 VS 2028
Figure 2. Vitamin E and Pioglitazone Features
Figure 3. Ocaliva Features
Figure 4. Elafibranor Features
Figure 5. Selonsertib and Cenicriviroc Features
Figure 6. Global NASH Therapeutic Drugs Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Provider Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. NASH Therapeutic Drugs Report Years Considered
Figure 11. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global NASH Therapeutic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global NASH Therapeutic Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global NASH Therapeutic Drugs Market Share by Players in 2021
Figure 15. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2021
Figure 17. North America NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
Figure 20. North America NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
Figure 21. United States NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
Figure 26. Europe NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific NASH Therapeutic Drugs Market Size Share by Region (2017-2028)
Figure 37. China NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
Figure 46. Latin America NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
Figure 57. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
Figure 58. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
Figure 59. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
Figure 60. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
Figure 61. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
Figure 62. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan Plc (Tobira) Bristol Myers Squibb Galmed Pharmaceuticals Genfit SA Gilead Sciences, Inc. Intercept Pharmaceuticals, Inc. Zydus Cadila